Developing and Implementing a New Prison-Based Buprenorphine Treatment Program.
about
Retention on buprenorphine is associated with high levels of maximal viral suppression among HIV-infected opioid dependent released prisonersResults of a pilot randomized controlled trial of buprenorphine for opioid dependent women in the criminal justice systemA randomized controlled trial of prison-initiated buprenorphine: prison outcomes and community treatment entryBuprenorphine Treatment for Probationers and Parolees.Opportunities to diagnose, treat, and prevent HIV in the criminal justice system.The Severity, Frequency, and Variety of Crime in Heroin-Dependent Prisoners Enrolled in a Buprenorphine Clinical Trial.Medication-assisted treatment for opioid dependence: making a difference in prisons.Linkage to care for HIV-infected heterosexual men in the United StatesRelease from incarceration, relapse to opioid use and the potential for buprenorphine maintenance treatment: a qualitative study of the perceptions of former inmates with opioid use disorder.Medication-assisted treatment research with criminal justice populations: challenges of implementation.Buprenorphine dose induction in non-opioid-tolerant pre-release prisonersDisparities in access to physicians and medications for the treatment of substance use disorders between publicly and privately funded treatment programs in the United States.Initiation of buprenorphine during incarceration and retention in treatment upon release."I Kicked the Hard Way. I Got Incarcerated." Withdrawal from Methadone During Incarceration and Subsequent Aversion to Medication Assisted Treatments.Gender Differences Among Prisoners With Pre-Incarceration Heroin Dependence Participating in a Randomized Clinical Trial of Buprenorphine Treatment.A randomized clinical trial of buprenorphine for prisoners: Findings at 12-months post-release.Medication-assisted therapy for opioid-dependent incarcerated populations in New Mexico: statewide efforts to increase access.
P2860
Q28729018-3159A266-B9EE-4014-BB24-E1274160372DQ30423352-1617A26C-3796-4310-8375-272651A451F0Q34030894-E33DD559-541E-4AF4-9434-FDCEAA188E8AQ34289480-4B561D5F-9156-4F50-A6A5-B8982856877BQ34472876-812A66B4-7744-48EA-96E9-341C2408B8AAQ34478651-EFBB8E73-8E06-4C8E-8949-23502518A2C4Q34589284-1F2594DE-696A-4D25-8C7A-1020AAEFAB62Q35019900-44FE40D8-A2B4-4070-BC31-514FFE8812B8Q35540686-44764E79-1108-4CC1-B987-EF268D442371Q35627363-FD1B7392-A725-4A16-A34E-D5897276F623Q36248890-2C73231A-72F6-48C5-B353-6E340A3670ACQ36597560-4D80E11F-FCFB-4491-A766-41C8E0D33496Q36948204-7209A615-B285-4AE4-8A8A-132AFD8057A0Q36955769-F6EB42BB-050C-4B1C-9A36-D49703474AF5Q37119769-183BC06C-A1F8-4C05-8250-92D0E5160F3EQ39009581-1139EC3A-BC46-4F93-953C-BF14AF871915Q44332613-9CCF6B8D-3405-4C36-A606-CC523C22C75E
P2860
Developing and Implementing a New Prison-Based Buprenorphine Treatment Program.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Developing and Implementing a New Prison-Based Buprenorphine Treatment Program.
@ast
Developing and Implementing a New Prison-Based Buprenorphine Treatment Program.
@en
type
label
Developing and Implementing a New Prison-Based Buprenorphine Treatment Program.
@ast
Developing and Implementing a New Prison-Based Buprenorphine Treatment Program.
@en
prefLabel
Developing and Implementing a New Prison-Based Buprenorphine Treatment Program.
@ast
Developing and Implementing a New Prison-Based Buprenorphine Treatment Program.
@en
P2093
P2860
P1476
Developing and Implementing a New Prison-Based Buprenorphine Treatment Program.
@en
P2093
Michael S Gordon
Robert P Schwartz
Terrence T Fitzgerald
Timothy W Kinlock
P2860
P304
P356
10.1080/10509670903534951
P577
2010-02-01T00:00:00Z